Frequently Asked Questions About the Conference
The GFN is the only international conference to focus on the role of safer nicotine products that help people switch from smoking. Safer nicotine products include e-cigarettes (vapes), nicotine pouches,oral tobaccos such as Swedish snus, and heated tobacco products. This is a rapidly evolving area, with many new non-combustible products emerging over the past ten to fifteen years.
The rapid development and use of safer nicotine products raises a number of challenging scientific questions about their safety, who uses them and why, and the impact on smoking. These products also raise challenges for governments who seek to understand what kind of policy and regulation is appropriate. The GFN examines the rapidly developing science in relation to nicotine and its use, including policy and regulatory responses.
This is the only global event that welcomes all stakeholders involved with new and safer nicotine products, including:
- consumers and consumer advocates;
- policy analysts;
- public health experts;
- parliamentarians and government officials;
- academics and researchers;
- product manufacturers and distributors;
- media representatives.
The first conference was held in 2014. This year marks the 8th annual GFN.
The GFN started in 2014 with 200 delegates from 26 countries. By 2019, it had grown to 600 delegates representing 80+ nations.The 2020 online edition attracted over 600 people from 92 countries.
We bring together the many people who might otherwise not have the opportunity to speak with each other. Unique among conferences on nicotine and smoking, we ensure that consumer and consumer advocacy organisations participate as well as manufacturers. These groups are often excluded from other international meetings and events, despite playing a critical role in informing and shaping the debates around safer nicotine products and tobacco harm reduction.
Many different groups are involved in, or affected by, developments in safer nicotine products. These include:
- consumers, including people who have switched to these products or are thinking of doing so;
- academics and researchers, who are faced with new research questions about the safety and use of these products;
- parliamentarians and government officials, who need to consider what kind of regulation is appropriate;
- manufacturers, involved in developing and marketing new products; and
- public health experts, who need to advise populations about smoking, smoking cessation and safer nicotine products.
Smoking tobacco is the most harmful way of using nicotine. It is the tars and gases in cigarette smoke that are harmful to health. Many people find it hard to stop smoking because they find it hard to go without nicotine. Making available lower risk products helps people to switch from smoking and avoid the associated risks. This is known as ‘tobacco harm reduction’.
Media representatives can express interest in attending the event by filling a form here. Please include details of the organisation you work for or, if freelance, which organisation has commissioned you. The deadline to apply for media accreditation is 15 May 2021.
The conference is funded by registration fees and does not receive any sponsorship from manufacturers, distributors or retailers of nicotine products, including pharmaceutical, electronic cigarette and tobacco companies.
We aim to make the conference as accessible as possible. The registration fee to attend the 2021 conference in person, in Liverpool, is as little as £60. Our online conference in 2021 is free to attend.